Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luella R, Manlucu"'
Autor:
Robert H. Brook, Chien-Wen Tseng, Carol M. Mangione, Allen L. Hixon, Luella R. Manlucu, R. Adams Dudley, Emmett B. Keeler
Publikováno v:
Journal of the American Geriatrics Society. 57:848-854
Author(s): Tseng, Chien-Wen; Dudley, R Adams; Brook, Robert H; Keeler, Emmett; Hixon, Allen L; Manlucu, Luella R; Mangione, Carol M | Abstract: ObjectivesMany elderly persons have drug benefits with coverage gaps, such as in Medicare Part D. Because
Autor:
Chien-Wen, Tseng, R Adams, Dudley, Robert H, Brook, Emmett, Keeler, Allen L, Hixon, Luella R, Manlucu, Carol M, Mangione
Publikováno v:
Journal of the American Geriatrics Society. 57(5)
Many elderly persons have drug benefits with coverage gaps, such as in Medicare Part D. Because beneficiaries who have such gaps must pay all drug costs, an accurate knowledge of gap thresholds and communication with providers about exceeding caps is
Autor:
Gracielle G Manipon, Joseph E. Blaney, Stephen S. Whitehead, Luella R Manlucu, Christopher T. Hanson, Kathryn A. Hanley, Brian R. Murphy
Publikováno v:
Vaccine. 22(25-26)
A dengue virus vaccine candidate, rDEN4Delta30, has been previously reported to be safe and immunogenic in humans, but a subset of vaccinees developed asymptomatic rash, elevation of liver enzymes and/or mild neutropenia. In the current study, mutati
Autor:
Brian R. Murphy, Lara E Gilmore, Luella R Manlucu, Stephen S. Whitehead, Joseph E. Blaney, Christopher T. Hanson, Kathryn A. Hanley
Publikováno v:
Virology. 312(1)
An acceptable live-attenuated dengue virus vaccine candidate should have low potential for transmission by mosquitoes. We have identified and characterized a mutation in dengue virus type 4 (DEN4) that decreases the ability of the virus to infect mos